EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 29 filers reported holding EVOKE PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $78,000 | -45.1% | 30,260 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $142,000 | +32.7% | 30,260 | 0.0% | 0.00% | +33.3% |
| Q2 2020 | $107,000 | +224.2% | 30,260 | +7.1% | 0.00% | +200.0% |
| Q1 2020 | $33,000 | +50.0% | 28,260 | +108.4% | 0.00% | 0.0% |
| Q4 2019 | $22,000 | +144.4% | 13,560 | +35.6% | 0.00% | – |
| Q3 2019 | $9,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,433,113 | $2,623,000 | 0.55% |
| Worth Venture Partners, LLC | 336,516 | $616,000 | 0.30% |
| Wambolt & Associates, LLC | 32,000 | $59,000 | 0.03% |
| Pure Financial Advisors, LLC | 17,647 | $32,000 | 0.00% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,540 | $6,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 179 | $0 | 0.00% |
| NORTHERN TRUST CORP | 42,121 | $77,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 16,101 | $29,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 159,979 | $292,000 | 0.00% |